PortalPublikationenExecutive summary. Expert consensus statement on the diagnos...

Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK

Standard

Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. / Hansmann, Georg; Apitz, Christian; Abdul-Khaliq, Hashim; Alastalo, Tero-Pekka; Beerbaum, Phillip; Bonnet, Damien; Dubowy, Karl-Otto; Gorenflo, Matthias; Hager, Alfred; Hilgendorff, Anne; Kaestner, Michael; Koestenberger, Martin; Koskenvuo, Juha W; Kozlik-Feldmann, Rainer; Kuehne, Titus; Lammers, Astrid E; Latus, Heiner; Michel-Behnke, Ina; Miera, Oliver; Moledina, Shahin; Muthurangu, Vivek; Pattathu, Joseph; Schranz, Dietmar; Warnecke, Gregor; Zartner, Peter.

in: HEART, Jahrgang 102 , Nr. Suppl 2, 05.2016, S. ii86-100.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung

Harvard

Hansmann, G, Apitz, C, Abdul-Khaliq, H, Alastalo, T-P, Beerbaum, P, Bonnet, D, Dubowy, K-O, Gorenflo, M, Hager, A, Hilgendorff, A, Kaestner, M, Koestenberger, M, Koskenvuo, JW, Kozlik-Feldmann, R, Kuehne, T, Lammers, AE, Latus, H, Michel-Behnke, I, Miera, O, Moledina, S, Muthurangu, V, Pattathu, J, Schranz, D, Warnecke, G & Zartner, P 2016, 'Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK', HEART, Jg. 102 , Nr. Suppl 2, S. ii86-100. https://doi.org/10.1136/heartjnl-2015-309132

APA

Hansmann, G., Apitz, C., Abdul-Khaliq, H., Alastalo, T-P., Beerbaum, P., Bonnet, D., Dubowy, K-O., Gorenflo, M., Hager, A., Hilgendorff, A., Kaestner, M., Koestenberger, M., Koskenvuo, J. W., Kozlik-Feldmann, R., Kuehne, T., Lammers, A. E., Latus, H., Michel-Behnke, I., Miera, O., ... Zartner, P. (2016). Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. HEART, 102 (Suppl 2), ii86-100. https://doi.org/10.1136/heartjnl-2015-309132

Vancouver

Hansmann G, Apitz C, Abdul-Khaliq H, Alastalo T-P, Beerbaum P, Bonnet D et al. Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. HEART. 2016 Mai;102 (Suppl 2):ii86-100. https://doi.org/10.1136/heartjnl-2015-309132

Bibtex

@article{1f426bcf0642456396f8001ba2911441,
title = "Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK",
abstract = "UNLABELLED: : The European Paediatric Pulmonary Vascular Disease (PVD) Network is a registered, non-profit organisation that strives to define and develop effective, innovative diagnostic methods and treatment options in all forms of paediatric pulmonary hypertensive vascular disease, including specific forms such as pulmonary arterial hypertension (PAH)-congenital heart disease, pulmonary hypertension (PH) associated with bronchopulmonary dysplasia, persistent PH of the newborn, and related cardiac dysfunction.METHODS: The writing group members conducted searches of the PubMed/MEDLINE bibliographic database (1990-2015) and held five face-to-face meetings with votings. Clinical trials, guidelines, and reviews limited to paediatric data were searched using the terms 'pulmonary hypertensio{\'n}' and 5-10 other keywords, as outlined in the other nine articles of this special issue. Class of recommendation (COR) and level of evidence (LOE) were assigned based on European Society of Cardiology/American Heart Association definitions and on paediatric data only, or on adult studies that included >10% children.RESULTS: A total of 9 original consensus articles with graded recommendations (COR/LOE) were developed, and are summarised here. The topics included diagnosis/monitoring, genetics/biomarker, cardiac catheterisation, echocardiography, cardiac magnetic resonance/chest CT, associated forms of PH, intensive care unit/ventricular assist device/lung transplantation, and treatment of paediatric PAH.CONCLUSIONS: The multipaper expert consensus statement of the European Paediatric PVD Network provides a specific, comprehensive, detailed but practical framework for the optimal clinical care of children with PH.",
keywords = "Adolescent, Child, Child, Preschool, Europe, Humans, Hypertension, Pulmonary/diagnosis, Infant, Infant, Newborn, Societies, Medical",
author = "Georg Hansmann and Christian Apitz and Hashim Abdul-Khaliq and Tero-Pekka Alastalo and Phillip Beerbaum and Damien Bonnet and Karl-Otto Dubowy and Matthias Gorenflo and Alfred Hager and Anne Hilgendorff and Michael Kaestner and Martin Koestenberger and Koskenvuo, {Juha W} and Rainer Kozlik-Feldmann and Titus Kuehne and Lammers, {Astrid E} and Heiner Latus and Ina Michel-Behnke and Oliver Miera and Shahin Moledina and Vivek Muthurangu and Joseph Pattathu and Dietmar Schranz and Gregor Warnecke and Peter Zartner",
note = "Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/",
year = "2016",
month = may,
doi = "10.1136/heartjnl-2015-309132",
language = "English",
volume = "102 ",
pages = "ii86--100",
journal = "HEART",
issn = "1355-6037",
publisher = "BMJ PUBLISHING GROUP",
number = "Suppl 2",

}

RIS

TY - JOUR

T1 - Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK

AU - Hansmann, Georg

AU - Apitz, Christian

AU - Abdul-Khaliq, Hashim

AU - Alastalo, Tero-Pekka

AU - Beerbaum, Phillip

AU - Bonnet, Damien

AU - Dubowy, Karl-Otto

AU - Gorenflo, Matthias

AU - Hager, Alfred

AU - Hilgendorff, Anne

AU - Kaestner, Michael

AU - Koestenberger, Martin

AU - Koskenvuo, Juha W

AU - Kozlik-Feldmann, Rainer

AU - Kuehne, Titus

AU - Lammers, Astrid E

AU - Latus, Heiner

AU - Michel-Behnke, Ina

AU - Miera, Oliver

AU - Moledina, Shahin

AU - Muthurangu, Vivek

AU - Pattathu, Joseph

AU - Schranz, Dietmar

AU - Warnecke, Gregor

AU - Zartner, Peter

N1 - Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

PY - 2016/5

Y1 - 2016/5

N2 - UNLABELLED: : The European Paediatric Pulmonary Vascular Disease (PVD) Network is a registered, non-profit organisation that strives to define and develop effective, innovative diagnostic methods and treatment options in all forms of paediatric pulmonary hypertensive vascular disease, including specific forms such as pulmonary arterial hypertension (PAH)-congenital heart disease, pulmonary hypertension (PH) associated with bronchopulmonary dysplasia, persistent PH of the newborn, and related cardiac dysfunction.METHODS: The writing group members conducted searches of the PubMed/MEDLINE bibliographic database (1990-2015) and held five face-to-face meetings with votings. Clinical trials, guidelines, and reviews limited to paediatric data were searched using the terms 'pulmonary hypertensioń' and 5-10 other keywords, as outlined in the other nine articles of this special issue. Class of recommendation (COR) and level of evidence (LOE) were assigned based on European Society of Cardiology/American Heart Association definitions and on paediatric data only, or on adult studies that included >10% children.RESULTS: A total of 9 original consensus articles with graded recommendations (COR/LOE) were developed, and are summarised here. The topics included diagnosis/monitoring, genetics/biomarker, cardiac catheterisation, echocardiography, cardiac magnetic resonance/chest CT, associated forms of PH, intensive care unit/ventricular assist device/lung transplantation, and treatment of paediatric PAH.CONCLUSIONS: The multipaper expert consensus statement of the European Paediatric PVD Network provides a specific, comprehensive, detailed but practical framework for the optimal clinical care of children with PH.

AB - UNLABELLED: : The European Paediatric Pulmonary Vascular Disease (PVD) Network is a registered, non-profit organisation that strives to define and develop effective, innovative diagnostic methods and treatment options in all forms of paediatric pulmonary hypertensive vascular disease, including specific forms such as pulmonary arterial hypertension (PAH)-congenital heart disease, pulmonary hypertension (PH) associated with bronchopulmonary dysplasia, persistent PH of the newborn, and related cardiac dysfunction.METHODS: The writing group members conducted searches of the PubMed/MEDLINE bibliographic database (1990-2015) and held five face-to-face meetings with votings. Clinical trials, guidelines, and reviews limited to paediatric data were searched using the terms 'pulmonary hypertensioń' and 5-10 other keywords, as outlined in the other nine articles of this special issue. Class of recommendation (COR) and level of evidence (LOE) were assigned based on European Society of Cardiology/American Heart Association definitions and on paediatric data only, or on adult studies that included >10% children.RESULTS: A total of 9 original consensus articles with graded recommendations (COR/LOE) were developed, and are summarised here. The topics included diagnosis/monitoring, genetics/biomarker, cardiac catheterisation, echocardiography, cardiac magnetic resonance/chest CT, associated forms of PH, intensive care unit/ventricular assist device/lung transplantation, and treatment of paediatric PAH.CONCLUSIONS: The multipaper expert consensus statement of the European Paediatric PVD Network provides a specific, comprehensive, detailed but practical framework for the optimal clinical care of children with PH.

KW - Adolescent

KW - Child

KW - Child, Preschool

KW - Europe

KW - Humans

KW - Hypertension, Pulmonary/diagnosis

KW - Infant

KW - Infant, Newborn

KW - Societies, Medical

U2 - 10.1136/heartjnl-2015-309132

DO - 10.1136/heartjnl-2015-309132

M3 - Other (editorial matter etc.)

C2 - 27053701

VL - 102

SP - ii86-100

JO - HEART

JF - HEART

SN - 1355-6037

IS - Suppl 2

ER -